Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Anti-mycotoxin drug, preparation method thereof and application thereof

An anti-fungal and drug technology, applied in the field of livestock and poultry drugs, can solve the problems such as the inability to effectively curb the harm of mycotoxins, the use effect is relatively large, and the secondary products are toxic, so as to enhance the detoxification function of the liver, improve resistance, eliminate The effect of mycotoxins

Inactive Publication Date: 2018-04-20
山东迅达康兽药有限公司
View PDF10 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The defect of this method is that: the feed may not provide an environment suitable for the action of the enzyme; the selectivity of the enzyme to the substrate is very high, sometimes absolute, so this type of method is also only effective for a certain toxin. Function; secondary products after enzymatic hydrolysis may be toxic; enzymes are not heat-resistant and are easily inactivated during feed processing
However, a single method has defects and disadvantages, and cannot effectively contain the hazards of mycotoxins; although there are some compound component mold removers on the market, their effects are single, and the effects of use are quite different.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-mycotoxin drug, preparation method thereof and application thereof
  • Anti-mycotoxin drug, preparation method thereof and application thereof
  • Anti-mycotoxin drug, preparation method thereof and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0061] A plant extract, which is composed of the following raw materials in parts by weight: 12 parts of astragalus, 3 parts of dandelion, 3 parts of motherwort, and 2 parts of bamboo leaves.

[0062] The specific preparation method is:

[0063] ① Weigh each Chinese medicine component, add 10 times the weight of water, boil and extract for 2 hours, and filter;

[0064] ② Add 8 times the weight of water to the above filter residue, boil and extract for 2 hours, and filter;

[0065] ③ Merge the filtrate in ①② and concentrate to a thick paste of 1 / 6 weight;

[0066] ④ Vacuum-dry the thick paste in ③, pulverize, and pass through an 80-mesh sieve to obtain the plant extract.

Embodiment 2

[0068] A plant extract, which consists of the following raw materials in parts by weight: 11 parts of astragalus, 5 parts of dandelion, 2 parts of motherwort, and 1 part of bamboo leaves.

[0069] The preparation method is the same as in Example 1.

Embodiment 3

[0071] A plant extract, which consists of the following raw materials in parts by weight: 12 parts of astragalus, 2 parts of dandelion, 3 parts of motherwort, and 2 parts of bamboo leaves.

[0072] The preparation method is the same as in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention discloses an anti-mycotoxin drug, a preparation method thereof and an application thereof, and belongs to the techncial field of livestock and poultry drugs. The drug is preparedfrom 8-15 parts of cell walls of saccharomyces cerevisiae, 8-16 parts of a plant extract, 6-14 parts of bacillus subtilis and 2-6 parts of an active coenzyme; and the plant extract consists of radixastragali, dandelion, herba leonuri and herba lophatheri at a weight ratio of (4-15):(2-5):(2-6):(1-4). Each component of the drug interacts with each other and commonly reaches effects of removing, relieving and dispelling toxins, and reducing prevalence and mortality of animals, and the anti-mycotoxin drug can also regulate immunity and enhances the toxin relieving functions of liver, has no adsorption effects on nutrient components and is conducive to a balanced nutrition intake of the animals, and enables the animals to grow healthily.

Description

technical field [0001] The invention belongs to the technical field of livestock and poultry medicines, and in particular relates to a medicine for resisting mycotoxins, a preparation method and application thereof. Background technique [0002] Mycotoxins are secondary metabolites produced by molds during their growth that are highly toxic to animals, humans and crops. There are currently more than 300 types of mycotoxins known. Mycotoxins that are common in animal husbandry and can directly affect animal growth, production performance and health are mainly produced by four fungal genera: Aspergillus (mainly secrete aflatoxin, ochratoxin, etc.), Penicillium (mainly secrete Toxin), Ergot (mainly secrete ergot toxin), Clostridium (mainly secrete vomitoxin, zearalenone, T-2 toxin, Fusarium moniliforme toxin, etc.). The toxins produced by various molds are different, and the degree of harm caused is also different. Among them, the most toxic ones are: aflatoxin, ochratoxin, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A23K10/30A23K10/18A23K10/16A23K20/174A23L5/20A61K36/899A61P39/02
CPCA23K10/16A23K10/18A23K10/30A23K20/174A23L5/273A61K36/288A61K36/481A61K36/533A61K36/899A61K2236/331A61K2236/39A61K2236/51A61K2300/00
Inventor 汪安国刘文利李丽
Owner 山东迅达康兽药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products